208 related articles for article (PubMed ID: 36706936)
1. Tripterygium wilfordii Hook F combination therapy with methotrexate for rheumatoid arthritis: An updated meta-analysis.
Luo Y; Hou X; Xi A; Luo M; Wang K; Xu Z
J Ethnopharmacol; 2023 May; 307():116211. PubMed ID: 36706936
[TBL] [Abstract][Full Text] [Related]
2. Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis.
Wang X; Zu Y; Huang L; Yu J; Zhao H; Wen C; Chen Z; Xu Z
Life Sci; 2017 Feb; 171():45-50. PubMed ID: 28088452
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the impact of Tripterygium wilfordii Hook F and Methotrexate treatment on radiological progression in active rheumatoid arthritis: 2-year follow up of a randomized, non-blinded, controlled study.
Zhou YZ; Zhao LD; Chen H; Zhang Y; Wang DF; Huang LF; Lv QW; Liu B; Li Z; Wei W; Li H; Liao X; Liu H; Liu X; Jin H; Wang J; Fei YY; Wu QJ; Zhang W; Shi Q; Zheng WJ; Zhang FC; Tang FL; Lipsky PE; Zhang X
Arthritis Res Ther; 2018 Apr; 20(1):70. PubMed ID: 29636089
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial.
Lv QW; Zhang W; Shi Q; Zheng WJ; Li X; Chen H; Wu QJ; Jiang WL; Li HB; Gong L; Wei W; Liu H; Liu AJ; Jin HT; Wang JX; Liu XM; Li ZB; Liu B; Shen M; Wang Q; Wu XN; Liang D; Yin YF; Fei YY; Su JM; Zhao LD; Jiang Y; Li J; Tang FL; Zhang FC; Lipsky PE; Zhang X
Ann Rheum Dis; 2015 Jun; 74(6):1078-86. PubMed ID: 24733191
[TBL] [Abstract][Full Text] [Related]
5. Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis.
Wang HL; Jiang Q; Feng XH; Zhang HD; Ge L; Luo CG; Gong X; Li B
BMC Complement Altern Med; 2016 Jul; 16():215. PubMed ID: 27411429
[TBL] [Abstract][Full Text] [Related]
6. 2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis.
Zhang X; Xia J; Jiang Y; Pisetsky DS; Smolen JS; Mu R; Dai S; Weinblatt ME; Kvien TK; Li J; Dörner T; Zhang Y; Lu L; Yang C; Yang P; Zhang Y; Xu C; Zhao Z; Lipsky PE
J Autoimmun; 2024 Jan; 142():103148. PubMed ID: 37967495
[TBL] [Abstract][Full Text] [Related]
7. Effect of cream, prepared with Tripterygium wilfordii Hook F and other four medicinals, on joint pain and swelling in patients with rheumatoid arthritis: a double-blinded, randomized, placebo controlled clinical trial.
Jiao J; Tang X; Gong X; Yin H; Jiang Q; Wei C
J Tradit Chin Med; 2019 Feb; 39(1):89-96. PubMed ID: 32186028
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of adalimumab combined with Tripterygium wilfordii Hook F in the treatment of patient with rheumatoid arthritis: A multicenter, open-label, randomized-controlled trial.
Luo F; Gau SY; Wu YX; Liao HL; Tang F; Zhong Q; Huang Y; Hou L; Liu ZQ; Cai JL; Cao YP; Lu DM; An Y; Lan WY; Liu C; Chen CM; Jia ET; Yao XM; Wei JC; Ma WK
Int J Rheum Dis; 2024 Jan; 27(1):e15031. PubMed ID: 38287544
[TBL] [Abstract][Full Text] [Related]
9. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome.
Chen Y; Gong Z; Chen X; Tang L; Zhao X; Yuan Q; Cai G
Cochrane Database Syst Rev; 2013 Aug; (8):CD008568. PubMed ID: 23934958
[TBL] [Abstract][Full Text] [Related]
10. A Systematic Review and Network Meta-Analysis about the Efficacy and Safety of
Wang HL; Zhao Q; Li W; Zhu HC; Lv L; Zhu ZH; Wang XX; Yang ZZ; Ma YC; Liu MX; Wang YW; Lai H; Liu CP; Yang YZ
Evid Based Complement Alternat Med; 2022; 2022():3181427. PubMed ID: 35591865
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of TCMs with anti-inflammatory effect in patients with rheumatoid arthritis: A network meta-analysis.
Fang J; Liu M; Huang Z; Ma Y; Wang Y; Zheng X; Lv L; Liu C; Li W; Zhu Z; Zhu H; Hu J; Wang Y; Wang H
Front Immunol; 2023; 14():1114930. PubMed ID: 36969172
[TBL] [Abstract][Full Text] [Related]
12. The Effectiveness and Safety of
Zhou YY; Xia X; Peng WK; Wang QH; Peng JH; Li YL; Wu JX; Zhang JY; Zhao Y; Chen XM; Huang RY; Jakobsson PJ; Wen ZH; Huang QC
Front Pharmacol; 2018; 9():356. PubMed ID: 29713281
[No Abstract] [Full Text] [Related]
13. A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of peony combined with methotrexate in rheumatoid arthritis.
Feng ZT; Xu J; He GC; Cai SJ; Li J; Mei ZG
Clin Rheumatol; 2018 Jan; 37(1):35-42. PubMed ID: 28748514
[TBL] [Abstract][Full Text] [Related]
14. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.
Singh JA; Hossain A; Mudano AS; Tanjong Ghogomu E; Suarez-Almazor ME; Buchbinder R; Maxwell LJ; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2017 May; 5(5):CD012657. PubMed ID: 28481462
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial.
Goldbach-Mansky R; Wilson M; Fleischmann R; Olsen N; Silverfield J; Kempf P; Kivitz A; Sherrer Y; Pucino F; Csako G; Costello R; Pham TH; Snyder C; van der Heijde D; Tao X; Wesley R; Lipsky PE
Ann Intern Med; 2009 Aug; 151(4):229-40, W49-51. PubMed ID: 19687490
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of tripterygium wilfordii Hook F plus TNF inhibitor for active rheumatoid arthritis: A multicentre, randomized, double-blind, triple-dummy controlled trial.
Zhang X; Yang H; Zuo X; Wu L; Peng J; Li Z; Li H; Ji W; Zhang L; Li X; Dai L; Lu L; Yang N; Wei W; Shuai Z; Jiang Y; Liu Y; Lipsky PE; Chen H;
Clin Immunol; 2023 Oct; 255():109749. PubMed ID: 37657525
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta-analysis.
Liu L; Zhao H; Sun X; Zheng Q; Luo Y; Ru Y; Zhang Y; Chen X; Zhu B; Yin C; Li B; Li X
BMC Complement Altern Med; 2018 Aug; 18(1):243. PubMed ID: 30170584
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Tripterygium Wilfordii Hook. F for Connective Tissue Disease-Associated Interstitial Lung Disease:A Systematic Review and Meta-Analysis.
Li Y; Zhu W; He H; Garov YA; Bai L; Zhang L; Wang J; Wang J; Zhou X
Front Pharmacol; 2021; 12():691031. PubMed ID: 34177599
[No Abstract] [Full Text] [Related]
19. Efficacy of tripterygium glycosides (TG) in rheumatoid arthritis as a disease-modifying anti-rheumatic drug (DMARD) in combination with conventional DMARDs: A systematic review and meta-analysis of randomized controlled trials.
Feng Z; Fu L; Wang J; Zhu Y; He X; Zhou L; Zhou X
Pharmacol Res; 2022 Oct; 184():106405. PubMed ID: 36028187
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness and safety of Tripterygium wilfordii glycosides combined with disease-modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis: A systematic review and meta-analysis of 40 randomized controlled trials.
Zheng W; Mei Y; Chen C; Cai L; Chen H
Phytother Res; 2021 Jun; 35(6):2902-2924. PubMed ID: 33368709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
